Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin
- 18 November 1996
- journal article
- Published by Wiley in FEBS Letters
- Vol. 397 (2-3), 201-206
- https://doi.org/10.1016/s0014-5793(96)01135-0
Abstract
We investigated the mechanisms that regulate the efficacy of agonists in the arginine-vasopressin (AVP)/oxytocin (OT) receptor system. In this paper, we present evidence that AVP, a full agonist of the vasopressin receptors, acts as a partial agonist on the oxytocin receptor. We also found that AVP becomes a full agonist when two aromatic residues of the oxytocin receptor are replaced by the residues present at equivalent positions in the vasopressin receptor subtypes. Our results indicate that these two residues modulate the response of the oxytocin receptor to the partial agonist AVPThis publication has 34 references indexed in Scilit:
- A novel G protein-coupled receptor mediating both vasopressin- and oxytocin-like functions of Lys-conopressin in Lymnaea stagnalisNeuron, 1995
- The Binding Site of Neuropeptide Vasopressin V1a ReceptorPublished by Elsevier BV ,1995
- Teleost isotocin receptor: structure, functional expression, mRNA distribution and phylogenyFEBS Letters, 1995
- Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuityTrends in Pharmacological Sciences, 1995
- An extracellular residue determines the agonist specificity of V2 vasopressin receptorsFEBS Letters, 1995
- MOLECULAR BIOLOGY OF DIABETES INSIPIDUSAnnual Review of Medicine, 1995
- Locating ligand-binding sites in 7tm receptors by protein engineeringCurrent Opinion in Biotechnology, 1994
- STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORSAnnual Review of Biochemistry, 1994
- Structure and expression of a human oxytocin receptorNature, 1992
- Molecular cloning and expression of a rat Via arginine vasopressin receptorNature, 1992